VFA
INO icon

Virtus Fund Advisers’s Inovio Pharmaceuticals INO Stock Holding History

Virtus Fund Advisers’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$334K Buy
+6,738
New +$418K ﹤0.01% 433
2014
Q3 		– Sell
-428
Closed -$55K – 1525
2014
Q2 		$55K Buy
+428
New +$50.5K ﹤0.01% 1791

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtus Fund Advisers's INO Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Inovio Pharmaceuticals (INO) in Q4 2017: 6,738 shares worth $334K. The stake represents ﹤0.01% of the portfolio and ranks #433 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in INO as recently as Q2 2014.

Virtus Fund Advisers first reported a position in INO in Q2 2014 and has held it in 2 quarters since. 133 funds tracked by Wall St. Rank hold INO as of Q4 2017.

  • Virtus Fund Advisers held 6,738 shares of Inovio Pharmaceuticals worth $334K as of Q4 2017.
  • Inovio Pharmaceuticals was a new Virtus Fund Advisers position in Q4 2017.
  • Inovio Pharmaceuticals made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #433 holding.
  • Virtus Fund Advisers first reported a position in Inovio Pharmaceuticals in Q2 2014 and has held it in 2 quarters since.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.